NETRIS Pharma
  • Our company
    • About us
    • Our team
    • Scientific Advisory Board
    • Clinical Advisors
  • Our Science
    • Concept and Focus on oncology
    • Therapeutic strategy
  • Portfolio
    • Pipeline
    • Netrin-1 Lead Program
  • Publications
  • News
  • Contact us
  • Our company
    • About us
    • Our team
    • Scientific Advisory Board
    • Clinical Advisors
  • Our Science
    • Concept and Focus on oncology
    • Therapeutic strategy
  • Portfolio
    • Pipeline
    • Netrin-1 Lead Program
  • Publications
  • News
  • Contact us

Discover our news

28 avril 2020
0

NETRIS Pharma welcomes its new CMO

By Netris Pharma | Actualités, Event
NETRIS Pharma is pleased to announce the arrival of Frédéric Le Bras, MD; as the new company Chief Medical Officer. Graduated from René Descartes University in Paris, Frédéric obtained his...
Read More
1 octobre 2019
1

BIO-Europe – Hamburg , 2019

By Netris Pharma | Actualités, Event
NETRIS Pharma will attend the 2019 Bio-Europe conference in Hamburg, Germany  (November 11th-13th). Our team members will be pleased to meet with you and discuss Business Development and investment opportunities. Please...
Read More
24 septembre 2019
0

ESMO Congress – Barcelona, 2019

By Netris Pharma | Actualités, Event
Dr Philippe Cassier, Principal Investigator of NETRIS Pharma Phase 1 dose-escalation clinical trial on solid tumors, will present the results of the trial at ESMO Conference in Barcelona. The presentation...
Read More
29 mars 2019
0

Colloque Cancers de la Femme – Paris, 2019

By Netris Pharma | Actualités, Event

NETRIS Pharma will attend the Colloque on Women Cancer in Paris (March 30th, 2019). In partnership with “La Ligue contre le Cancer” Association, the following theme will be discussed by…

Read More
3 janvier 2019
0

Annual J.P. Morgan Healthcare Conference – San Francisco, 2019

By Netris Pharma | Actualités, Event

NETRIS Pharma will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California (January 07th-10th, 2019). Our team members attending the event will be pleased to meet you for…

Read More
13 avril 2018
0

Presentation at PEGS – Boston, 2018

By Netris Pharma | Actualités, Event

NETRIS Pharma will attend PEGS 2018 event in Boston, MA (April 30th-May 04th). Our CEO, Pr. Patrick Mehlen, will give a presentation on April 30th within the Oncology stream – Antibodies…

Read More
19 février 2018
0

BIO-Europe Spring – Amsterdam, 2018

By Netris Pharma | Actualités, Event

NETRIS Pharma will attend the BIO-Europe Spring 2018 event in Amsterdam, Netherlands (March 12th-14th). Our team members attending the event will be pleased to meet you for discussing opportunities with…

Read More
5 janvier 2018
0

Annual J.P. Morgan Healthcare Conference – San Francisco, 2018

By Netris Pharma | Actualités, Event

NETRIS Pharma will attend the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California (January 08th-11th, 2018). Our team members attending the event will be pleased to meet you…

Read More

Contact

NETRIS PHARMA
Centre Léon Bérard
28 rue Laennec
69008 LYON
France
+33 (0)4 78 78 29 53
contact@netrispharma.com

Links

  • Mentions légales
  • Careers

News

  • NETRIS Pharma Announces First Patient Dosed in Phase Ib/II 31 décembre 2020
  • Bio Partnering @ JPM – January 2021 26 décembre 2020
  • NETRIS Pharma successfully completes a €16.1m Series A 23 décembre 2020
  • Press release – Clinical Trial Collaboration Agreement with MSD (Merck US) 5 mai 2020

Copyright © 2016 NETRIS Pharma | Sitemap page

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.OK